Shares of CVS Health Corp. CVS, +1.82% fell 0.3% in premarket trading Wednesday, after the drugstore chain and health care services company’s fourth-quarter results beat expectations by wide margins, but lowered its full-year outlook because of “elevated medical cost trends.” Net income fell to $2.05 billion, or $1.58 a share, from $2.33 billion, or $1.77 a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per share of $2.12 beat the FactSet consensus of $1.98. Revenue grew 11. ...

CVS Health on Wednesday reported fourth-quarter revenue and adjusted earnings that topped expectations, but the company cut its full-year profit outlook, citing higher medical costs that are dogging the broader insurance industry.The company lowered its 2024 adjusted earnings forecast to at least $8.30 per share, down from a previous guidance of at least $8.50 per share. Analysts surveyed by LSEG were expecting full-year adjusted earnings of $8.49 per share. CVS also cut its unadjusted earnings guidance to ...

Since betting on the individual companies of the Standard and Poor’s 500 offers a solid chance for long-term profitability, it stands to reason that going for undervalued S&P 500 stocks could potentially net you robust returns. In a way, it’s like having your cake and eating it too.For as long as I can remember, sports fans have long wondered what would happen if the weakest team in the NFL went head-to-head with the strongest team in college football. Chances are, the pro team should run circles around the ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to_________ Commission file number: 001-01011 CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 05-0494040 (State or ...

The “Magnificent Seven” stocks may garner the lion’s share of market attention right now, but while there may be strong potential with some of “Mag 7” names, check out opportunities making far fewer headlines, like undervalued large-cap stocks.Although there are many large-cap value stocks that are “value traps,” or stocks trading at a low valuation that fail to perform well because of growth issues or other types of headwinds, there are stocks that are both undervalued, and that have catalysts in place tha ...

Wall Street analysts forecast that CVS Health (CVS) will report quarterly earnings of $2 per share in its upcoming release, pointing to a year-over-year increase of 0.5%. It is anticipated that revenues will amount to $90.46 billion, exhibiting an increase of 7.9% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed the ...

The market expects CVS Health (CVS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2023. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released ...

CVS Health (CVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Over the past month, shares of this drugstore chain and pharmacy benefits manager have returned -6.9%, compared to the Zacks S&P 500 composite's +3.4% change. During this period, the Zacks Retail - Pharmacies and Drug Stores industry, which CVS Health falls in, has lost 7.5%. The key question now is: What could be the sto ...

CVS Health Corp (NYSE:CVS) stock was last seen up 0.6% at $73.40, extending a bounce off the $70 level. While the security carries a 16.9% year-over-year deficit and last week fell under its 50-day moving average for the first time since December, there's indication this underperformance could soon be a thing of the past. CVS Health stock's most recent pullback placed it within a trendline with historically bullish implications.stock was last seen up 0.6% at $73.40, extending a bounce off the $70 level. Whi ...

The latest trading session saw CVS Health (CVS) ending at $73, denoting a +1.4% adjustment from its last day's close. The stock's performance was ahead of the S&P 500's daily loss of 0.07%. On the other hand, the Dow registered a gain of 0.16%, and the technology-centric Nasdaq decreased by 0.36%.Shares of the drugstore chain and pharmacy benefits manager have depreciated by 8.84% over the course of the past month, underperforming the Retail-Wholesale sector's gain of 1.02% and the S&P 500's gain of 3.05%.T ...